ISPE's 40th Annual Meeting - GIPAM will be presenting results of a cancer registry data analysis on RW treatment and OS in aNSCLC patients

Written By Sabrina Müller

The 2024 ISPE Scientific Program ‎Committee has accepted our research abstract reporting the results of a lung cancer registry analysis describing the real-world treatment pattern and overall survival of stage III and IV Non‑Small‑Cell Lung Cancer (NSCLC) patients to be presented on August 24-28 at the Estrel Congress Center, Berlin, Germany.

We are looking forward to our presentation and an interesting conference.

More Articles

Sabrina Müller
Previous

A New Era for EU Drug Evaluations? Understanding the European Commission’s Updated JCA Guidelines
Next

GIPAM overcompensates its carbon emissions by 4000%!